The9 expects 15%-16% stake in Nanyang Biologics after planned Nasdaq SPAC merger

Reuters2026/08/21 12:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

The9’s investee Nanyang Biologics moved closer to a Nasdaq listing via a planned business combination with RF Acquisition Corp II.
On Aug. 19, 2026, RFAI shareholders backed the deal, clearing a key step toward trading under ticker “NYB.”
The9 expects to own about 15% to 16% of the combined Nasdaq-listed company once the transaction closes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The9 Limited published the original content used to generate this news brief on August 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

The9 expects 15%-16% stake in Nanyang Biologics after planned Nasdaq SPAC merger

You may also like

Crypto prices